SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-20-022807
Filing Date
2020-02-19
Accepted
2020-02-19 16:10:45
Documents
79
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K inva-20191231x10k49b2bc.htm   iXBRL 10-K 2710454
2 EX-4.9 ex-4d9.htm EX-4.9 14465
3 EX-21.1 ex-21d1.htm EX-21.1 9068
4 EX-23.1 ex-23d1.htm EX-23.1 3724
5 EX-23.2 ex-23d2.htm EX-23.2 6728
6 EX-31.1 ex-31d1.htm EX-31.1 11424
7 EX-31.2 ex-31d2.htm EX-31.2 10630
8 EX-32 ex-32.htm EX-32 13113
14 GRAPHIC inva-20191231x10k49b2bc001.jpg GRAPHIC 69072
  Complete submission text file 0001104659-20-022807.txt   10363836

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA inva-20191231.xsd EX-101.SCH 62504
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inva-20191231_cal.xml EX-101.CAL 77726
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inva-20191231_def.xml EX-101.DEF 286291
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20191231_lab.xml EX-101.LAB 650189
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20191231_pre.xml EX-101.PRE 488015
26 EXTRACTED XBRL INSTANCE DOCUMENT inva-20191231x10k49b2bc_htm.xml XML 1912470
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30319 | Film No.: 20629762
SIC: 2834 Pharmaceutical Preparations